Blogs

Pope RT cover still

Do You Have to be Overweight for GLP-1s to Work?

Janet Pope, MD, MPH, FRCPC

Are there any data that GLP-1 RA drugs can be effective if a person has a normal BMI? 

Magrey RT cover image

Obesity in Rheumatic Diseases: More than just a Comorbidity

Marina Magrey, MD
A few years ago, when I would see a patient with rheumatic disease and increased BMI, I would often document it as obesity as a comorbidity, recommend weight loss and exercise, and then move on. My approach has changed.
Dr. Al Kim

Obesity and Lupus: Coconspirator or Comorbidity?

Alfred Kim, MD, PhD

Dr. Al Kim, St. Louis, discusses the effects of obesity on lupus activity, organ damage, complement levels and mTor activation.

Puzzle pieces

Comorbidities in RA: Focus on Difficult-to-Treat Disease

Elena Nikiphorou, MD, PhD
The presence of comorbidities naturally complicates treatment choice, patient adherence to medication and patient outcomes, increasing also the risk of making RA ‘difficult-to-treat’.
stack of blocks

Comorbidities in Rheumatoid Arthritis: A Precarious Stack of Blocks

Cynthia S. Crowson, PhD

Comorbidities can pile up like a stack of blocks for people with rheumatoid arthritis (RA).  At the time when RA is diagnosed, they already have more comorbidities than their peers, and after RA diagnosis they accumulate comorbidities faster than their peers.

turmeric CAM

Complementary and Alternative Therapies in Psoriasis and Psoriatic Arthritis

Rachel Tate, DO
It’s been reported that approximately one-third to one-half of patients with psoriatic arthritis will try supplements and other complementary and alternative medicinal (CAM) practices without discussing with their rheumatologists.  Of those, nearly 90% of PsA patients using CAM report benefits!  Here is your updated review on common supplement data in psoriasis and PsA. 
×